https://quankun.shinyapps.io/sarcOS/; DFS:
Conclusions: The antioxidant gene signature models established in this study can be novel prognostic predictors for sarcoma." name="description">
Figure 6. Prediction model of OS in patients with sarcoma. (A) Nomogram constructed based on the risk signature and other independent risk factors identified by Cox analysis. (B) ROC analysis of OS prediction in patients with sarcoma. (C) Calibration plot for evaluating the estimation accuracy of the nomogram. (D) Two-year decision curve analysis (DCA) comparing the model and other clinical features. (E) Four-year DCA comparing the model and other clinical features. (F) Six-year DCA comparing the model and other clinical features.